Physician profile
Fadi C Constantine
NPI 1871752774
$4,077.06
in general payments reported to CMS, 2019-2025
14 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $206 · 2021: $295 · 2022: $1,009 · 2023: $629 · 2024: $1,079 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,063.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $939.68 | 2019-2022 | |
| Mentor Worldwide LLC | $875.62 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $866.25 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Acera Surgical, INC. | $252.53 | 2024 | Restrata Wound Matrix |
| Tepha INC | $213.62 | 2019-2020 | |
| Sientra, INC. | $184.82 | 2021-2022 | |
| Tela Bio, INC. | $183.99 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Becton, Dickinson and Company | $153.29 | 2024 | |
| Rti Surgical, INC | $143.00 | 2022 | |
| Baxter Healthcare | $105.91 | 2025 | Artiss |
| Axogen | $61.97 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Musculoskeletal Transplant Foundation INC. | $55.63 | 2019-2023 | |
| Cardiva Medical, INC. | $20.75 | 2021 | |
| Galderma Laboratories, L.P. | $20.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Constantine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.